MUSC Hollings Cancer Center

He's guided 16 junior researchers (assistant professor or below)?in the past 15 years to receive more than $19 million in federal funding – that certainly seems worthy of the?Peggy Schachte Research Mentor Award! Congratulations to Hollings' own Matthew Carpenter, Ph.D., co-leader of the Cancer Prevention and Control research program, who was honored at the?2024 James W. Colbert Lectureship and MUSC Faculty Awards and Recognition Ceremony.? Thank you for your work Dr. Carpenter!

When Hollings' Dr. Marvella Ford and SC State University's Dr. Judith Salley launched SC CADRE, they envisioned building a research infrastructure at SCSU and creating a pipeline of new cancer researchers focused on cancer disparities. Today, we're celebrating with SCSU that Dr. Courtney Thomas has become the first SCSU researcher in modern memory to be awarded an independent NIH grant. She is researching the role that the protein?calreticulin (CRT) may play in prostate cancer.

Raymond N. DuBois, M.D., Ph.D., director of Hollings, discusses research into the increase in early onset cancer with Bobbi Conner, host of Health Focus on SC Public Radio.?

A team of MUSC Hollings Cancer Center researchers has discovered one way in which triple-negative breast cancer (TNBC) cells become resistant to immunotherapy and have tested a two-pronged treatment strategy that was able to restore sensitivity to immunotherapy in a preclinical model. The team, led by Besim Ogretmen, Ph.D., SmartState Endowed Chair in Lipidomics and Drug Discovery at MUSC, reports its findings in Cell Reports.

MUSC Health dermatologist Graciela De Jesus, M.D., is partnering with the Hollings Hereditary Cancer Clinic to offer a dedicated clinic for people with genetic mutations that put them at increased risk of melanoma.?

We are excited to Welcome Dr. Michael Bobian to our head and neck surgery team. Dr. Bobian is a dedicated and experienced Head and Neck Surgical Oncologist and Microvascular Reconstructive Surgeon. He specializes in caring for patients with tumors involving the head and neck, including the throat, tonsils, mouth, jaw, voice box, skin, sinuses, skull base, thyroid, and salivary glands. He is skilled in using minimally invasive and robotic techniques and has unique training in whole body and head and neck reconstruction.

Do you care for breast cancer patients? Come to our 2024 Multidisciplinary Breast Cancer Symposium on Sept. 28. MUSC employees are free -- email Alisha Gourdine at?gourdial [at]?musc.edu for the code. Register here:?https://lnkd.in/dFFtxie5

Happy Labor Day to our incredible MUSC Hollings Cancer Center team and community! Whether you're in the lab, classroom, or caring for patients, your hard work and dedication make a world of difference. Today, let's take a moment to rest, relax, and appreciate all that we do together. #LaborDay

We're thrilled to Welcome Dr. Anthony Dominick to the Hollings team! Dr. Dominick was born and raised in the Kansas City area. He was inspired early on in his training, by his mentors and developed a passion for malignant hematology. After completion of training, he spent 4 years in private practice caring for a variety of patients with hematologic conditions in eastern North Carolina. He joined MUSC to pursue his interest and passion for caring for patients with multiple myeloma. He also has secondary clinical interest in lymphoproliferative disorders.

We are excited to Welcome Dr. Jonathan Alexander. He was born and raised in Cape Town, South Africa, before moving to the United States to begin his medical training. He received his medical degree from St George’s University School of Medicine and completed his internal medicine residency at the University of Louisville School of Medicine. He completed a fellowship in Hematology/Oncology at MUSC and a fellowship in Bone Marrow Transplant & Cellular Therapy at Stanford University. His clinical and research interests include myeloid neoplasms with a focus on acute myeloid leukemia and bone marrow transplant.